TAR-210

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAR-210, covering 2026-03-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer [Phase 3]

See pricing